Extendicare Stock Forecast for 2023 - 2025 - 2030
Updated on 05/01/2024
Extendicare Stock Forecast and Price Target
Extendicare's stock price reaches the average target of C$8.00 by 2025 as expected recently by two notable experts, there would be a potential upside of approximately 10.34% from the last closing price in April, 2024. This possible increase is based on a high estimate of C$8.50 and a low estimate of C$7.50. If you are looking to invest in the stock, it's important to research and compare different companies.
10.34% Upside
Extendicare Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Extendicare's Price has decreased from C$17.31 to C$0.00 – a 100.00% drop. In the coming year, analysts are expecting an increase in Fair Value, predicting it will reach C$12.15 – an increase of 100.00%. Over the next seven years, experts anticipate that Fair Value growth for Extendicare will be 100.00%.
Extendicare Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Revenue for Extendicare has grown by 12.66%, going from C$1.16B to C$1.30B. In the following year, 2 experts forecast that Extendicare's Revenue will decrease by 1.60%, to C$1.28B. Over the next seven years, experts anticipate that Revenue growth for Extendicare will be 0.90%.
Extendicare Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, Extendicare's Dividend per Share has decreased by 0.00%, going from C$0.48 to C$0.48. 3 analysts predict Extendicare's Dividend per Share will decrease by 0.00% in the next year, reaching C$0.48. For the next seven years, the forecast is for Dividend per Share to grow by 256.12%.
Extendicare EBITDA Forecast for 2023 - 2025 - 2030
Extendicare's EBITDA has decreased by 16.48% In the last three years, from C$113.97M to C$95.19M. In the following year, the 2 analysts surveyed believe that Extendicare's EBITDA will decrease by 10.65%, reaching C$85.05M. According to professionals, by 2030, Extendicare's EBITDA will have decreased by 0.71%, falling down to C$94.51M.
Extendicare EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Extendicare's EBIT has decreased from C$77.67M to C$62.96M – a 18.94% drop! In the next year, analysts expect EBIT to reach C$176.14M – an increase of 179.76%. For the next seven years, the forecast is for EBIT to grow by 384.19%.
Extendicare EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Extendicare's EPS has decreased from C$0.47 to C$0.00 – a 100.00% drop. In the coming year, analysts are expecting an increase in EPS, predicting it will reach C$0.33 – an increase of 100.00%. Over the next seven years, experts anticipate that EPS growth for Extendicare will be 100.00%.